Sunniva (CSE: SNN) (OTCQX: SNNVF) has penned a white label
services agreement to provide Cannabis Strategic Ventures, Inc. (OTC: NUGS)
with top-quality cannabis extracts for its Pure Organix™ brand. In discussing
the venture, Sunniva CEO Tony Holler stated, “As one of the highest quality
producers in the marketplace, we believe we are in an excellent position to
provide brand product manufacturing services for Cannabis Strategic. Both of
our firms share the vision of becoming leaders in providing clean, medical
grade cannabis products to consumers.”
To view the full article, visit http://ibn.fm/Loayv
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is based in Los Angeles and is
focused on supporting entrepreneurial growth within the fast-growing legal
cannabis sector. The company recently completed a name and symbol change from
Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel
solutions that are tailor-made to match the growth dynamics of cannabis
cultivators, manufacturers, dispensaries, and other cannabis marketplace
participants. Cannabis Strategic Ventures is publicly traded on the OTC Markets
with the stock symbol NUGS. For more information, visit the company’s website
at www.CannabisStrategic.com
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically
integrated cannabis company operating in the world’s two largest cannabis
markets – Canada and California – where it is committed to delivering safe,
high-quality products and services at scale and creating trusted Sunniva
branded cannabis products. The company’s vision is to become one
of the lowest cost, highest quality vertically integrated cannabis
producers in the markets it serves by building large scale purpose-built
current cGMP designed greenhouses
and expansion of retail locations, offering better quality
assurance with cannabis products free from pesticides, providing
better customer access to cannabis education and sourcing better
therapeutic delivery devices. Sunniva’s management and board of
directors have a proven track record for creating significant shareholder value
both in the healthcare and biotech industries. For more information, visit the
company’s website at www.Sunniva.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
